The TCSPP Master of Science in Clinical Psychopharmacology is a two-year program designed to educate students who wish to expand their knowledge base in psychopharmacology and medical conditions that are relevant to mental health care. Students will learn how to increase their current competency in assessment, diagnosis, and intervention, and engage in case-based learning that will enhance their collaborative practice skills.
The program uses online teaching methods and applied case-based learning to train current and aspiring practitioners to integrate medical approaches into their client care. In addition to the 31 credit hour didactic courses, the program includes a research project
Program Learning Outcomes
Upon successful of this program students will be able to:
- Be able to perform a reliable, valid and clinically sound assessment, formulate a clinical diagnosis and generate treatment options individualized to the specific characteristics and therapeutic goals of the patient.
- Accepts and evaluates feedback and supervision from both medical and mental health professionals non- defensively and actively seeks to modify his/her behavior appropriately.
- Collaborate with people differing from the student in terms of age, gender, race, ethnicity, cultural background, religious difference, sexual orientation, or differing ability. The student will be able to listen to and learn from the perspectives of others who differ from him/herself.
- Apply the knowledge on identity related to race, ethnicity, gender, sexual orientation, socioeconomic status, age, religious belief, and ability, to promote more accurate and individualized clinical psychopharmacology assessment and treatment interventions.
- Able to perform a competent clinical assessment, formulate a diagnosis and generate treatment options that delineate ethical practices.
- Able to show ethical professional behavior according to a code of ethics.
- Able to show collaborative and team-oriented professional relationships with other medical and mental health professionals.
- Apply the theories of clinical psychopharmacology to assessment, diagnosis and treatment management.
- Able to use descriptive statistics and statistical procedures common to clinical psychopharmacology such as meta-analysis in a clinical research project.
- Evaluate and apply research findings to clinical psychopharmacological practice.
Application to The Chicago School of Professional Psychology’s Master of Science in Clinical Psychopharmacology program is open to any person who has earned a bachelor’s degree in psychology or related field (e.g., nursing) from a regionally-accredited institution, and, who meets The Chicago School entrance requirements.
- Completed application
- $50 application fee
- An undergraduate (or graduate, if applicable) GPA of a 3.0 or higher on a 4.0 scale is expected for admission.
- Applicants must submit official transcripts from all schools where a degree was earned. It is recommended that transcripts are submitted from all schools where credit was received to enhance their applications.
The Chicago School of Professional Psychology reviews applications on a rolling basis. Once review begins, complete applications will be considered by the Admission Committee and applicants will be notified regarding the admission decision. The Chicago School of Professional Psychology does not share information or provide any feedback regarding admission decisions.
If a student is offered admission and in order to secure a place in the incoming class, a non-refundable tuition deposit of $250 will be required by the deposit deadline indicated in the offer of admission. The non-refundable deposit will be applied in full toward the student’s tuition upon enrollment.
The following policies are located under Academic Policies and Procedures : Academic Calendar, Admissions Requirements, Attendance, Satisfactory Academic Progress, Service Learning, and Transfer Credit/Course Waiver. Click the link above for detailed information.
Licensure for Prescriptive Authority
The MS Clinical Psychopharmacology program is aligned with the didactic curriculum of the 2009 American Psychological Association (APA) Recommended Postdoctoral Education and Training Program in Psychopharmacology, but is not an APA-designated program. A slowly growing number of states are extending prescriptive authority to licensed clinical psychologists that have received additional education and training in psychopharmacology. States may choose to model their educational requirements for prescriptive authority on the APA recommended curriculum. In addition to coursework requirements, states may also require supervised clinical experience, a component that is not a part of the program at TCSPP. It is a student’s responsibility to research their state’s requirements should they wish to pursue prescriptive authority
At this time there are three states where prescriptive authority is available for licensed psychologists. The M.S. Clinical Psychopharmacology program meets the degree, program, and curriculum requirements for eligibility for licensure as a medical psychologist in Louisiana. In addition to educational requirements, candidates must possess an unrestricted license to practice psychology in the state and complete an application process which includes a fee, background check, and passage of a national exam in psychopharmacology. The M.S. Clinical Psychopharmacology program does not meet requirements for prescriptive authority in New Mexico and Illinois.